NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

封閉式藥物轉移系統 (CSTD) 的全球市場(~ 2026):類型(膜間/無針)/技術(隔膜/隔室/過濾)/組件/最終用戶(醫院和診所/癌症中心)按地區

Closed System Transfer Devices Market by Type (Membrane-to-Membrane, Needleless), Technology (Diaphragm based, Compartmentalized, Filtration), Component, End User (Hospitals & Clinics, Oncology Centers), and Region - Global Forecast to 2026

出版商 MarketsandMarkets 商品編碼 1026971
出版日期 內容資訊 英文 230 Pages
訂單完成後即時交付
價格
封閉式藥物轉移系統 (CSTD) 的全球市場(~ 2026):類型(膜間/無針)/技術(隔膜/隔室/過濾)/組件/最終用戶(醫院和診所/癌症中心)按地區 Closed System Transfer Devices Market by Type (Membrane-to-Membrane, Needleless), Technology (Diaphragm based, Compartmentalized, Filtration), Component, End User (Hospitals & Clinics, Oncology Centers), and Region - Global Forecast to 2026
出版日期: 2021年08月30日內容資訊: 英文 230 Pages
簡介

封閉式藥物轉移系統(CSTDs)的市場規模在預測期內將保持 19.7% 的複合年增長率,從 2021 年的 8.14 億美元預計成長到到 2026 年的 20.2 億美元的規模。

細胞毒性藥物的有害作用、癌症發病率增加、抗癌藥物批准量增加以及危險藥物安全處理監管指南的改進等因素推動了市場的增長。我是。

按關閉機制,2020 年誘餌鎖系統部門的份額最大,為 32.5%。此外,在預測期內,該行業的規模預計將以 19.2% 的複合年增長率增長,從 2021 年的 2.641 億美元增至 2026 年的 6.368 億美元。然而,在增長率方面,由於壓力均衡機製而具有高效率和低成本的顏色對顏色對準系統部門預計將比誘餌鎖定係統增長更快。

本報告探討了全球封閉式藥物轉移系統 (CSTD) 市場,並分析了市場定義和概述、價值鏈、新型冠狀病毒感染 (COVID-19) 等市場影響因素。、法律環境、技術/專利分析,市場規模轉變/預測,按關閉機制/類型/組件/技術/最終用戶/地區/主要國家/地區,競爭環境,主要公司概況等各種類別細分總結。

第 1 章介紹

第 2 章調查方法

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章市場概覽

    • 促進因素
    • 抑制因素
    • 市場機會
    • 挑戰
  • 波特五力分析
  • 行業趨勢
  • 產品功能/價格
  • CSTDS 的使用/採用:按地區
  • 監管指南
  • 監管分析
  • 生態系統映射
  • 價值鏈
  • 供應鏈
  • 專利分析
  • 主要進出口市場
  • COVID-19:影響分析
  • YC-YCC 換班

第 6 章市場分析/預測:按開關機構

  • 誘餌鎖系統
  • 推車系統
  • 點擊鎖定系統
  • 顏色到顏色的對齊系統

第 7 章市場分析/預測:按類型

  • 膜間系統
  • 無針系統

第 8 章市場分析/預測:按組件

  • 小瓶存取裝置
  • 注射器安全裝置
  • 袋/線接入裝置
  • 配件

第 9 章市場分析/預測:按技術

  • 隔膜裝置
  • 隔間設備
  • 空氣淨化/過濾裝置

第 10 章市場分析/預測:按最終用戶

  • 醫院/診所
  • 癌症中心
  • 其他

第 11 章市場分析/預測:按地區

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第 12 章競爭形勢

  • 大公司的戰略
  • 收入分成
  • 市場份額分析
  • 各大公司研發
  • 主要公司收入分析:按地區
  • 企業評估象限
  • 競爭基準
  • 競爭形勢/趨勢

第 13 章公司簡介

  • 主要公司
    • BECTON, DICKINSON AND COMPANY
    • ICU MEDICAL
    • EQUASHIELD
    • B. BRAUN MELSUNGEN
    • JMS
    • BAXTER INTERNATIONAL
    • SIMPLIVIA HEALTHCARE
    • CORVIDA MEDICAL
    • YUKON MEDICAL
    • CODAN MEDIZINISCHE GERATE
    • VICTUS
    • CARAGEN
  • 其他龍頭企業
    • WEST PHARMACEUTICALS SERVICES
    • VYGON SA
    • PRACTIVET
    • CORNING INCORPORATED
    • TERUMO CORPORATION
    • CARDINAL HEALTH
    • ERASER MEDICAL
    • INSUNG MEDICAL
    • NEEDLELESS CORPORATION
    • ADVCARE MEDICAL
    • ELCAM MEDICAL
    • EPIC MEDICAL
    • EDGE PHARMA

第 14 章附錄

目錄
Product Code: MD 6925

The closed system transfer devices (CSTDs) market is projected to reach USD 2,002 million by 2026 from USD 814 million in 2021, at a CAGR of 19.7% during the forecast period. Market growth is largely driven by the harmful effects (lingering role) of cytotoxic drugs, rising incidence of cancer, an increasing number of oncology drug approvals, and improving regulatory guidelines regarding the safe handling of hazardous drugs.

"Colour-to-colour alignment system is expected to witness the fastest growth in the forecast period."

Based on the closing mechanism, the market is segmented into Luer-lock systems, color-to-color alignment systems, click-to-lock systems, and push-to-turn systems. In 2020, the Luer-lock systems segment accounted for the highest share of 32.5% of the market. This segment is expected to reach USD 636.8 million by 2026 from USD 264.1 million in 2021, at a CAGR of 19.2%. However, the color-to-color alignment systems segment is expected to grow at the highest rate because of its higher efficiency due to pressure equalization mechanisms and low cost.

" Membrane-to-membrane systems is expected to witness the fastest growth in the forecast period."

Based on device type, the market is segmented into membrane-to-membrane systems and needleless systems. In 2020, the membrane-to-membrane systems segment accounted for the largest share of 71.01% of the CSTDs market. This segment is expected to reach USD 1,488.9 million by 2026 from USD 583.1 million in 2021, at a CAGR of 20.6%. The large share and high growth of this segment are attributed to their ease of operation and lower risk of contamination associated with double-membrane containment systems.

"Diaphragm-based devices segment accounted for the largest share of closed system transfer devices market in 2020"

Based on technology, the CSTDs market is segmented into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices. In 2020, the diaphragm-based devices segment accounted for the largest share of 43.63% of the market. This segment is expected to reach USD 829.4 million by 2026 from USD 353.1 million in 2021, at a CAGR of 18.6%. The large share of this segment is mainly due to the ease of operation and safety provided by these devices. The compartmentalized devices segment is expected to grow at the highest CAGR of 23.8% during the forecast period due to their lower cost.

"Vial access devices segment accounted for the largest share of closed system transfer devices market in 2020"

Based on components, the CSTDs market is segmented into vial access devices, syringe safety devices, bag/line access devices, and accessories. In 2020, the vial access devices segment accounted for the largest share of 33.08% of the market. The large share of this segment is mainly due to the increasing adoption of CSTD products and vial access devices by oncology nurses to transfer hazardous drugs from packaged vials to the infusion bag or the patient.

"Hospitals & Clinics accounted for the largest share of closed system transfer devices market in 2020"

Based on end users, the market is segmented into hospitals & clinics, oncology centers, and other end users. In 2020, hospitals & clinics accounted for the largest share of 84.41% of the CSTDs market. The large share and high growth of this segment are mainly due to the strong financial capabilities of hospitals for purchasing high-priced CSTDs, the large cancer patient pool, and the need to comply with regulatory guidelines.

"North America accounted for the largest share of the closed system transfer devices market in 2020"

In 2020, North America accounted for the largest share of the market. The market in North America is characterized by easy accessibility to advanced technologies, high awareness about CSTD among oncologists, nurses, and pharmacists, the presence of many CSTD manufacturing players in this region, and the high incidence and prevalence of cancer. However, the APAC market is expected to witness the highest CAGR of 22.1% during the forecast period. The rising incidence of cancer, increasing demand for better healthcare services in developing economies, and increasing focus of international players on emerging markets such as India and China drive the growth of the Asia Pacific market.

A breakdown of the primary participants (supply-side) for the closed system transfer devices market referred to for this report is provided below:

  • By Company Type: Tier 1-42%, Tier 2-37%, and Tier 3-21%
  • By Designation: C-level-39%, Director Level-33%, and Others-28%
  • By Region: North America-64%, Europe-17%, Asia Pacific-7%, Latin America- 6%, and Middle East and Africa- 6%

Some of the key players in the closed system transfer device market are Becton, Dickinson and Company (US), ICU Medical (US), B Braun Melsungen (Germany), JMS (Japan), Equashield (US), Baxter International (US), West Pharmaceuticals Services (US), Simplivia Healthcare (Israel), Corvida Medical (US), Yukon Medical (US), CODAN Medizinische Gerate GmbH & Co KG (Germany), Victus (US), Caragen (Ireland), Vygon SA (US), Practivet (US), Corning Incorporated (US), Terumo Corporation (Japan), Cardinal Health (US), Eraser Medical (Turkey) and Insung Medical (South Korea) among others. The study includes an in-depth competitive analysis of these key players in the closed system transfer devices market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the closed system transfer devices market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by closing mechanism, type, component, technology, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the closed system transfer devices market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSION AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • FIGURE 1 CLOSED SYSTEM TRANSFER DEVICES MARKET SEGMENTATION
    • FIGURE 2 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION
    • 1.3.1 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 3 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 4 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION
    • FIGURE 10 REVENUE ANALYSIS OF THE TOP THREE PUBLIC COMPANIES: CLOSED SYSTEM TRANSFER DEVICES MARKET (2020)
    • FIGURE 11 BOTTOM-UP APPROACH
    • FIGURE 12 TOP-DOWN APPROACH
    • FIGURE 13 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE CLOSED SYSTEM TRANSFER DEVICES MARKET (2021-2026)
    • FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 15 DATA TRIANGULATION METHODOLOGY
  • 2.4 ASSUMPTIONS FOR THE STUDY
  • 2.5 LIMITATIONS
    • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: CLOSED SYSTEM TRANSFER DEVICES MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 16 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2021 VS. 2026 (USD MILLION)
    • FIGURE 17 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 18 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
    • FIGURE 19 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 20 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 21 GEOGRAPHIC SNAPSHOT: CLOSED SYSTEM TRANSFER DEVICES MARKET

4 PREMIUM INSIGHTS

  • 4.1 CLOSED SYSTEM TRANSFER DEVICES MARKET OVERVIEW
    • FIGURE 22 THE RISING INCIDENCE OF CANCER IS DRIVING THE GROWTH OF THE CLOSED SYSTEM TRANSFER DEVICES MARKET
  • 4.2 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET OVERVIEW
    • FIGURE 23 DIAPHRAGM-BASED DEVICES ACCOUNTED FOR THE LARGEST SHARE OF THE APAC CLOSED SYSTEM TRANSFER DEVICES MARKET IN 2020
  • 4.3 CLOSED SYSTEM TRANSFER DEVICES MARKET: REGIONAL MIX
    • FIGURE 24 NORTH AMERICA TO DOMINATE THE MARKET THROUGHOUT THE FORECAST PERIOD
  • 4.4 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
    • FIGURE 25 CHINA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • 4.5 CLOSED SYSTEM TRANSFER DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS
    • FIGURE 26 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
    • FIGURE 27 CLOSED SYSTEM TRANSFER DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.1.1 DRIVERS
      • 5.1.1.1 Rising incidence of cancer
    • FIGURE 28 GLOBAL CANCER INCIDENCE (2008-2030)
    • TABLE 3 CANCER RATES, BY COUNTRY (2018)
    • TABLE 4 US: NEW CANCER CASES (2017-2020)
      • 5.1.1.2 The increasing number of oncology drug approvals
    • TABLE 5 FDA APPROVALS: NOVEL PRESCRIPTION CANCER DRUGS IN 2018
      • 5.1.1.3 Increasing use of CSTDs to combat the harmful effects of cytotoxic or antineoplastic drugs
      • 5.1.1.4 Growing emphasis on the implementation of occupational health and safety standards
    • TABLE 6 LIST OF NATIONAL/LOCAL REGULATORY BODIES RECOMMENDING THE USE OF CSTDS FOR THE SAFE HANDLING OF HAZARDOUS DRUGS, BY COUNTRY
    • 5.1.2 RESTRAINTS
      • 5.1.2.1 High cost of implementation of CSTDs and lack of reimbursement
    • TABLE 7 AVERAGE ANNUAL COSTS ASSOCIATED WITH THE IMPLEMENTATION OF VARIOUS CSTD SYSTEMS (USD)
      • 5.1.2.2 Lack of compliance with regulatory guidelines in developing countries
    • 5.1.3 OPPORTUNITIES
      • 5.1.3.1 Increasing application of CSTDs in other therapeutic areas
      • 5.1.3.2 Increasing adoption in emerging economies due to rising healthcare expenditure
    • 5.1.4 CHALLENGES
      • 5.1.4.1 Gaps with existing CSTDs
    • TABLE 8 ISSUES, CHALLENGES, AND POTENTIAL SOLUTIONS REGARDING THE SAFE HANDLING OF HAZARDOUS DRUGS
      • 5.1.4.2 Low awareness among nurses about CSTDs
  • 5.2 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 9 CLOSED SYSTEM TRANSFER DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.2.1 THREAT OF NEW ENTRANTS
      • 5.2.1.1 Growth in the medication delivery and management segment
      • 5.2.1.2 Demand for safe drug compounding and handling devices
      • 5.2.1.3 Highly concentrated market
      • 5.2.1.4 Poor financing environment
      • 5.2.1.5 Stringent regulatory environment
    • 5.2.2 THREAT OF SUBSTITUTES
      • 5.2.2.1 Unavailability of potential safe drug handling systems
      • 5.2.2.2 Combination and integration of multiple technologies
    • 5.2.3 BARGAINING POWER OF SUPPLIERS
      • 5.2.3.1 Institutional technology providers
      • 5.2.3.2 Substantially innovative technologies
      • 5.2.3.3 Dysfunctional companies
    • 5.2.4 BARGAINING POWER OF BUYERS
      • 5.2.4.1 Few buyers and many sellers
      • 5.2.4.2 Buy-out threat
      • 5.2.4.3 Point of differentiation
    • 5.2.5 INTENSITY OF COMPETITIVE RIVALRY
      • 5.2.5.1 Highly concentrated industry
      • 5.2.5.2 Similar funding source
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 AUTOMATED COMPOUNDING OF HAZARDOUS DRUGS USING ROBOTIC SYSTEMS
    • 5.3.2 EMERGING TECHNOLOGIES FOR RAPID DETECTION TESTS TO FACILITATE ROUTINE MONITORING AND SAFE HANDLING OF HAZARDOUS DRUGS
  • 5.4 PRODUCT FEATURES AND PRICING ANALYSIS
    • TABLE 10 COMPARATIVE ANALYSIS OF COMMERCIALLY AVAILABLE CSTDS BASED ON PRODUCT FEATURES
  • 5.5 UTILIZATION/ADOPTION OF CSTDS, BY REGION
    • TABLE 11 INTENSITY OF UTILIZATION/ADOPTION OF VARIOUS TYPES OF CSTDS, BY REGION
  • 5.6 REGULATORY GUIDELINES
    • TABLE 12 STRINGENCY OF REGULATIONS FOR THE ADOPTION OF CSTDS, BY REGION
    • 5.6.1 USP <800> REGULATIONS
    • 5.6.2 NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH
    • TABLE 13 NIOSH CLASSIFICATION OF HAZARDOUS DRUGS
    • TABLE 14 NIOSH HAZARDOUS DRUG ADMINISTRATION RECOMMENDATIONS AND <USP 800> REQUIREMENTS
    • 5.6.3 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
    • TABLE 15 NIOSH AND ASHP DEFINITIONS OF HAZARDOUS DRUGS
    • 5.6.4 INTERNATIONAL SOCIETY OF ONCOLOGY PHARMACY PRACTITIONERS
  • 5.7 REGULATORY ANALYSIS
  • 5.8 ECOSYSTEM MAPPING
    • FIGURE 29 CLOSED SYSTEM TRANSFER DEVICES MARKET: ECOSYSTEM (2020)
  • 5.9 VALUE CHAIN ANALYSIS
    • FIGURE 30 VALUE CHAIN ANALYSIS: CLOSED SYSTEM TRANSFER DEVICES
  • 5.10 SUPPLY CHAIN ANALYSIS
    • FIGURE 31 SUPPLY CHAIN ANALYSIS: CLOSED SYSTEM TRANSFER DEVICES MARKET
  • 5.11 PATENT ANALYSIS
    • FIGURE 32 PATENT ANALYSIS: CLOSED SYSTEM TRANSFER DEVICES MARKET
  • 5.12 KEY MARKETS FOR IMPORT AND EXPORT (TRADE ANALYSIS FOR CLOSED SYSTEM TRANSFER DEVICES)
    • TABLE 16 IMPORT VALUE OF CLOSED SYSTEM TRANSFER DEVICES FOR TOP 10 COUNTRIES IN 2020
  • 5.13 COVID-19 IMPACT ANALYSIS
    • 5.13.1 COVID-19 HEALTH ASSESSMENT
    • 5.13.2 COVID-19 ECONOMIC ASSESSMENT
    • 5.13.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 33 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • 5.13.4 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE CLOSED SYSTEM TRANSFER DEVICES MARKET
  • 5.14 YC-YCC SHIFT
    • FIGURE 34 YC-YCC SHIFT IN THE CLOSED SYSTEM TRANSFER DEVICES MARKET

6 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM

  • 6.1 INTRODUCTION
    • TABLE 17 TYPES OF CLOSING MECHANISMS IN THE CURRENTLY AVAILABLE CSTDS
    • TABLE 18 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
  • 6.2 LUER-LOCK SYSTEMS
    • 6.2.1 LUER-LOCK MECHANISMS REDUCE THE RISK OF EXPOSURE, REQUIRE FEWER COMPONENTS, AND GENERATE LESS BIOHAZARDOUS WASTE- KEY ADVANTAGES DRIVING GROWTH
    • TABLE 19 LUER-LOCK CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.3 PUSH-TO-TURN SYSTEMS
    • 6.3.1 HIGH ADOPTION OF PHASEAL, A PIONEER IN THE CSTD MARKET- A KEY MARKET DRIVER
    • TABLE 20 PUSH-TO-TURN CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.4 CLICK-TO-LOCK SYSTEMS
    • 6.4.1 THE USER-FRIENDLY NATURE OF CLICK-TO-LOCK MECHANISMS DRIVES THEIR ADOPTION AMONG END USERS
    • TABLE 21 CLICK-TO-LOCK CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.5 COLOR-TO-COLOR ALIGNMENT SYSTEMS
    • 6.5.1 LOW SYSTEM COST, ALONG WITH THE ADVANTAGES OFFERED, INCREASES THE ADOPTION OF THESE SYSTEMS AMONG PHARMACISTS, ONCOLOGISTS, AND NURSES
    • TABLE 22 COLOR-TO-COLOR ALIGNMENT CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

7 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 23 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 7.2 MEMBRANE-TO-MEMBRANE SYSTEMS
    • 7.2.1 MEMBRANE-TO-MEMBRANE SYSTEMS PROVIDE A DOUBLE LAYER OF PROTECTION FOR THE SAFE TRANSFER OF HAZARDOUS DRUGS
    • TABLE 24 LEADING MANUFACTURERS OF MEMBRANE-TO-MEMBRANE SYSTEMS
    • TABLE 25 MEMBRANE-TO-MEMBRANE SYSTEMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.3 NEEDLELESS SYSTEMS
    • 7.3.1 CHEMOLOCK IS THE FIRST FDA-APPROVED NEEDLELESS CSTD SYSTEM
    • TABLE 26 LEADING MANUFACTURERS OF NEEDLELESS SYSTEMS
    • TABLE 27 NEEDLELESS SYSTEMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

8 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT

  • 8.1 INTRODUCTION
    • TABLE 28 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
  • 8.2 VIAL ACCESS DEVICES
    • 8.2.1 INCREASING REGULATORY COMPLIANCE TO DRIVE THE ADOPTION OF VIAL ACCESS DEVICES IN HOSPITALS & ONCOLOGY CENTERS
    • TABLE 29 VIAL ACCESS COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES
    • TABLE 30 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR VIAL ACCESS DEVICES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.3 SYRINGE SAFETY DEVICES
    • 8.3.1 ADVANTAGES SUCH AS EASE OF USE AND LEAK PREVENTION ARE DRIVING THE ADOPTION OF THESE DEVICES GLOBALLY
    • TABLE 31 SYRINGE SAFETY COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES
    • TABLE 32 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR SYRINGE SAFETY DEVICES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.4 BAG/LINE ACCESS DEVICES
    • 8.4.1 HIGH COMPATIBILITY OF BAG/LINE ACCESS DEVICES DRIVES MARKET GROWTH
    • TABLE 33 BAG/LINE ACCESS COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES
    • TABLE 34 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR BAG/LINE ACCESS DEVICES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.5 ACCESSORIES
    • 8.5.1 MAJOR CSTDS REQUIRE DEDICATED ADMINISTRATION SETS, WHICH DRIVES GROWTH IN THE ACCESSORIES MARKET
    • TABLE 35 ACCESSORIES FOR CLOSED SYSTEM TRANSFER DEVICES
    • TABLE 36 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR ACCESSORIES, BY COUNTRY, 2019-2026 (USD MILLION)

9 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY

  • 9.1 INTRODUCTION
    • TABLE 37 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
  • 9.2 DIAPHRAGM-BASED DEVICES
    • 9.2.1 DIAPHRAGM-BASED DEVICES DOMINATE THE CLOSED SYSTEM TRANSFER DEVICES MARKET DUE TO THE EASE OF USE & SAFETY PROVIDED DURING THE HANDLING OF HAZARDOUS DRUGS
    • TABLE 38 DIAPHRAGM-BASED DEVICES AVAILABLE IN THE MARKET
    • TABLE 39 DIAPHRAGM-BASED CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.3 COMPARTMENTALIZED DEVICES
    • 9.3.1 COMPARTMENTALIZED DEVICES TO WITNESS THE HIGHEST GROWTH IN THE MARKET DURING THE FORECAST PERIOD
    • TABLE 40 COMPARTMENTALIZED DEVICES AVAILABLE IN THE MARKET
    • TABLE 41 COMPARTMENTALIZED CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.4 AIR CLEANING/FILTRATION DEVICES
    • 9.4.1 AIR CLEANING DEVICES INCORPORATE AN ACTIVATED CARBON OR HYDROPHOBIC FILTER TO HELP REDUCE THE OUTFLOW OF CONTAMINANTS
    • TABLE 42 AIR CLEANING/FILTRATION DEVICES AVAILABLE IN THE MARKET
    • TABLE 43 AIR CLEANING/FILTRATION CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

10 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 44 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.2 HOSPITALS & CLINICS
    • 10.2.1 HOSPITALS FORM THE LARGEST END-USER SEGMENT OF THE CLOSED SYSTEM TRANSFER DEVICES MARKET
    • TABLE 45 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 10.3 ONCOLOGY CENTERS
    • 10.3.1 INCREASING REGULATORY MANDATES TO DRIVE THE ADOPTION OF CSTDS IN ONCOLOGY CENTERS & CLINICS
    • TABLE 46 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR ONCOLOGY CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 10.4 OTHER END USERS
    • TABLE 47 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)

11 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION

  • 11.1 INTRODUCTION
    • FIGURE 35 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • TABLE 48 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 36 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT
    • TABLE 49 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 50 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 51 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 52 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 53 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 54 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 US dominates the North American market primarily due to the presence of leading CSTD manufacturing companies & the high burden of cancer
    • TABLE 55 US: KEY MACROINDICATORS
    • TABLE 56 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 57 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 58 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 59 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 60 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Increasing prevalence of cancer to drive the growth of the Canadian market
    • TABLE 61 CANADA: KEY MACROINDICATORS
    • TABLE 62 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 63 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 64 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 65 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 66 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.3 EUROPE
    • FIGURE 37 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT
    • TABLE 67 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 68 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 69 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 70 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 71 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 72 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 Germany to witness the highest growth in the European market
    • TABLE 73 GERMANY: KEY MACROINDICATORS
    • TABLE 74 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 75 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 76 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 77 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 78 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.2 UK
      • 11.3.2.1 High cost of CSTDs to restrain the market growth
    • TABLE 79 UK: KEY MACROINDICATORS
    • TABLE 80 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 81 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 82 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 83 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 84 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 High cancer prevalence and the high healthcare expenditure in the country to drive market growth in France
    • TABLE 85 FRANCE: KEY MACROINDICATORS
    • TABLE 86 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 87 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 88 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 89 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 90 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.4 ITALY
      • 11.3.4.1 Increasing geriatric population and the subsequent increase in the prevalence of cancer to drive the market for closed system transfer devices in Italy
    • TABLE 91 ITALY: KEY MACROINDICATORS
    • TABLE 92 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 93 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 94 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 95 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 96 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Lack of specific regulations about CSTDs is restraining the growth of this market
    • TABLE 97 SPAIN: KEY MACROINDICATORS
    • TABLE 98 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 99 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 100 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 101 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 102 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.3.6 REST OF EUROPE
    • TABLE 103 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 104 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 105 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 106 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 107 ROE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • FIGURE 38 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT
    • TABLE 108 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 109 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 110 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 111 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 112 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 113 APAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.4.1 JAPAN
      • 11.4.1.1 Japan to dominate the APAC CSTDs market
    • TABLE 114 JAPAN: KEY MACROINDICATORS
    • TABLE 115 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 116 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 117 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 118 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 119 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 The large patient pool provides significant growth opportunities in China
    • TABLE 120 CHINA: KEY MACROINDICATORS
    • TABLE 121 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 122 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 123 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 124 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 125 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 Low manufacturing costs and skilled workforce are attracting outsourcing and investment to India
    • TABLE 126 INDIA: KEY MACROINDICATORS
    • TABLE 127 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 128 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 129 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 130 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 131 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 11.4.4 REST OF APAC
    • TABLE 132 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 133 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 134 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 135 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 136 ROAPAC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.5 LATIN AMERICA
    • 11.5.1 RISING CANCER INCIDENCE TO DRIVE MARKET GROWTH IN LATAM
    • TABLE 137 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 138 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 140 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 141 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.6 MIDDLE EAST AND AFRICA
    • 11.6.1 MEA MARKET TO GROW AT A SLOWER RATE THAN LATIN AMERICA
    • TABLE 142 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2019-2026 (USD MILLION)
    • TABLE 143 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 145 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 146 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • FIGURE 39 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE CLOSED SYSTEM TRANSFER DEVICE MARKET
  • 12.3 REVENUE SHARE ANALYSIS
    • 12.3.1 REVENUE ANALYSIS FOR KEY PLAYERS IN THE CLOSED SYSTEM TRANSFER DEVICES MARKET
    • FIGURE 40 REVENUE ANALYSIS FOR KEY PLAYERS IN THE CLOSED SYSTEM TRANSFER DEVICES MARKET IN THE PAST FIVE YEARS
  • 12.4 MARKET SHARE ANALYSIS
    • 12.4.1 CLOSED SYSTEM TRANSFER DEVICES MARKET (2020)
    • FIGURE 41 SHARE OF LEADING COMPANIES IN THE GLOBAL CLOSED SYSTEM TRANSFER DEVICES MARKET (2020)
    • TABLE 147 CLOSED SYSTEM TRANSFER DEVICES MARKET: DEGREE OF COMPETITION
  • 12.5 R&D ASSESSMENT OF KEY PLAYERS
  • 12.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
  • 12.7 COMPANY EVALUATION QUADRANT
    • 12.7.1 COMPANY EVALUATION QUADRANT: CLOSED SYSTEM TRANSFER DEVICES MARKET
      • 12.7.1.1 Stars
      • 12.7.1.2 Pervasive players
      • 12.7.1.3 Emerging leaders
      • 12.7.1.4 Participants
    • FIGURE 42 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPANY EVALUATION MATRIX, 2020
  • 12.8 COMPETITIVE BENCHMARKING
    • 12.8.1 OVERALL COMPANY FOOTPRINT
    • TABLE 148 OVERALL COMPANY FOOTPRINT (20 COMPANIES)
    • TABLE 149 COMPANY FOOTPRINT: BY CLOSING MECHANISM (20 COMPANIES)
    • TABLE 150 COMPANY FOOTPRINT: BY TYPE (20 COMPANIES)
    • TABLE 151 COMPANY FOOTPRINT: BY COMPONENT (20 COMPANIES)
    • TABLE 152 COMPANY FOOTPRINT: BY TECHNOLOGY (20 COMPANIES)
    • TABLE 153 COMPANY FOOTPRINT: BY END USER (20 COMPANIES)
    • TABLE 154 COMPANY FOOTPRINT: BY REGION (20 COMPANIES)
  • 12.9 COMPETITIVE SITUATIONS AND TRENDS
    • 12.9.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 155 PRODUCT LAUNCHES & APPROVALS (2018-MAY 2021)
    • 12.9.2 DEALS
    • TABLE 156 DEALS (2018-MAY 2021)
    • 12.9.3 OTHER DEVELOPMENTS
    • TABLE 157 OTHER DEVELOPMENTS (2018-MAY 2021)

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 13.1.1 BECTON, DICKINSON AND COMPANY
    • TABLE 158 BD: BUSINESS OVERVIEW
    • FIGURE 43 BD: COMPANY SNAPSHOT
    • 13.1.2 ICU MEDICAL
    • TABLE 159 ICU MEDICAL: BUSINESS OVERVIEW
    • FIGURE 44 ICU MEDICAL: COMPANY SNAPSHOT
    • 13.1.3 EQUASHIELD
    • TABLE 160 EQUASHIELD: BUSINESS OVERVIEW
    • 13.1.4 B. BRAUN MELSUNGEN
    • TABLE 161 B. BRAUN MELSUNGEN: BUSINESS OVERVIEW
    • FIGURE 45 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
    • 13.1.5 JMS
    • TABLE 162 JMS: BUSINESS OVERVIEW
    • FIGURE 46 JMS: COMPANY SNAPSHOT
    • 13.1.6 BAXTER INTERNATIONAL
    • TABLE 163 BAXTER INTERNATIONAL.: BUSINESS OVERVIEW
    • FIGURE 47 BAXTER INTERNATIONAL: COMPANY SNAPSHOT
    • 13.1.7 SIMPLIVIA HEALTHCARE
    • TABLE 164 SIMPLIVIA HEALTHCARE: BUSINESS OVERVIEW
    • 13.1.8 CORVIDA MEDICAL
    • TABLE 165 CORVIDA MEDICAL: BUSINESS OVERVIEW
    • 13.1.9 YUKON MEDICAL
    • TABLE 166 YUKON MEDICAL: BUSINESS OVERVIEW
    • 13.1.10 CODAN MEDIZINISCHE GERATE
    • TABLE 167 CODAN MEDIZINISCHE GERATE: BUSINESS OVERVIEW
    • 13.1.11 VICTUS
    • TABLE 168 VICTUS: BUSINESS OVERVIEW
    • 13.1.12 CARAGEN
    • TABLE 169 CARAGEN: BUSINESS OVERVIEW
  • 13.2 OTHER PLAYERS
    • 13.2.1 WEST PHARMACEUTICALS SERVICES
    • TABLE 170 WEST PHARMACEUTICALS SERVICES: BUSINESS OVERVIEW
    • FIGURE 48 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT (2020)
    • 13.2.2 VYGON SA
    • TABLE 171 VYGON: BUSINESS OVERVIEW
    • 13.2.3 PRACTIVET
    • TABLE 172 PRACTIVET: BUSINESS OVERVIEW
    • 13.2.4 CORNING INCORPORATED
    • TABLE 173 CORNING INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2020)
    • 13.2.5 TERUMO CORPORATION
    • TABLE 174 TERUMO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT
    • 13.2.6 CARDINAL HEALTH
    • TABLE 175 CARDINAL HEALTH: BUSINESS OVERVIEW
    • FIGURE 51 CARDINAL HEALTH: COMPANY SNAPSHOT
    • 13.2.7 ERASER MEDICAL
    • TABLE 176 ERASER MEDICAL: BUSINESS OVERVIEW
    • 13.2.8 INSUNG MEDICAL
    • TABLE 177 INSUNG MEDICAL: BUSINESS OVERVIEW
    • 13.2.9 NEEDLELESS CORPORATION
    • 13.2.10 ADVCARE MEDICAL
    • 13.2.11 ELCAM MEDICAL
    • 13.2.12 EPIC MEDICAL
    • 13.2.13 EDGE PHARMA
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 AVAILABLE CUSTOMIZATIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS